title: Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection.
authors.forename: Nicola
authors.initials: N
authors.lastname: Abrescia
authors.forename: Maurizio
authors.initials: M
authors.lastname: D'Abbraccio
authors.forename: Mario
authors.initials: M
authors.lastname: Figoni
authors.forename: Annunziata
authors.initials: A
authors.lastname: Busto
authors.forename: Ettore
authors.initials: E
authors.lastname: Butrico
authors.forename: Mario
authors.initials: M
authors.lastname: De Marco
authors.forename: Rosaria
authors.initials: R
authors.lastname: Viglietti
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D000480:Alkynes; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D048588:Benzoxazines; D003521:Cyclopropanes; D005260:Female; D015497:HIV-1 / Q000187:drug effects; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000503:physiopathology; D010078:Oxazines / Q000009:adverse effects*
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; C098320:efavirenz